CANB Financials: Can B Corp AI Analysis

Home

Stock

CANB

Financials

CANB Financial

Can B Corp

0%

$0

At close: Mar 24, 16:00:00 GMT-4

0%

$0

Post-market: Mar 24, 17:23:38 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is CANB?

Nascent Pharma Holdings, Inc. is a pharmaceutical intellectual property company. The company is headquartered in Hicksville, New York and currently employs 12 full-time employees. The company went IPO on 2011-03-11. Nascent has certain patents using liquid formulations containing cannabinoids which are used in such products as vape cartridges, edibles, pills, gummies, tinctures, oils, concentrates and more. The firm is reestablishing the production of the Longevity Brand Superfood drink mix for Brooke Burke Body, Inc.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

CANB Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	1	2	6	4	1	2
Revenue Growth (YoY)	-50%	-67%	50%	300%	-50%	--
Cost of Revenue	1	1	4	1	0	0
Gross Profit	0	0	2	2	1	1
Selling, General & Admin	9	4	12	--	--	6
Research & Development	--	--	--	--	--	--
Operating Expenses	7	7	16	13	8	7
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-13	-9	-14	-12	-8	-5
Income Tax Expense	0	0	0	0	0	0
Net Income	-13	-9	-14	-12	-8	-5
Net Income Growth	30%	-36%	17%	50%	60%	25%
Shares Outstanding (Diluted)	65.43	12.59	3.57	1.34	0.23	0.13
Shares Change (YoY)	465%	252.99%	166%	470%	72%	124%
EPS (Diluted)	-0.2	-0.77	-4.18	-9.05	-37.67	-42.99
EPS Growth	-78%	-82%	-54%	-76%	-12%	-36%
Free Cash Flow	0	-1	-3	-8	-1	-4
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	0%	0%	33.33%	50%	100%	50%
Operating Margin	-700%	-350%	-233.33%	-250%	-700%	-250%
Profit Margin	-1,300%	-450%	-233.33%	-300%	-800%	-250%
Free Cash Flow Margin	0%	-50%	-50%	-200%	-100%	-200%
EBITDA	-7	-6	-13	-10	-7	-5
EBITDA Margin	-700%	-300%	-216.66%	-250%	-700%	-250%
D&A For EBITDA	0	1	1	0	0	0
EBIT	-7	-7	-14	-10	-7	-5
EBIT Margin	-700%	-350%	-233.33%	-250%	-700%	-250%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are Can B Corp's key financial statements?



According to the latest financial statement (Form-10K), Can B Corp has a total asset of $10, Net loss of $-9

What are the key financial ratios for CANB?



Can B Corp's Current ratio is 0.9, has a Net margin is -450, sales per share of $0.15.

How is Can B Corp's revenue broken down by segment or geography?



Can B Corp largest revenue segment is Hemp Derived Products, at a revenue of 1,336,117 in the most earnings release.For geography, United States is the primary market for Can B Corp, at a revenue of 2,155,744.

Is Can B Corp profitable?



no, according to the latest financial statements, Can B Corp has a net loss of $-9

Does Can B Corp have any liabilities?



yes, Can B Corp has liability of 11

How many outstanding shares for Can B Corp?



Can B Corp has a total outstanding shares of 32.71

Can B Corp (CANB) Financial

CANB Stock Price Chart